Etrolizumab Biosimilar (Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody)
Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
Product Specifications
Target
Etrolizumab Biosimilar (Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR8330 1 Each
1- (2-Chloro-4-nitrophenyl) -4- (2-hydroxyethyl) piperazine
Sign In for Pricing
View Details 